| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | US6503504 In vitro cell growth to form tissue containing at least partially foreign DNA sequence which mediates production of the bioactive compound; implanting mass into an organism; treating diseases |
| 01/07/2003 | US6503503 Allogeneic cellular vaccine |
| 01/07/2003 | US6503501 Targetable vector particles |
| 01/07/2003 | US6503273 Tissue engineered blood vessels and methods and apparatus for their manufacture |
| 01/07/2003 | CA2182398C Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions |
| 01/07/2003 | CA2104598C Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/06/2003 | CA2392549A1 Acetyl-coa carboxylase subunits |
| 01/04/2003 | CA2351156A1 A bioprocess for the generation of pluripotent cell derived cells and tissues |
| 01/03/2003 | WO2003001249A2 Modulating photoreactivity in a cell |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | WO2003001198A1 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 01/03/2003 | WO2003001197A1 Assay for toxin induced neuronal degeneration and viability in c. elegans |
| 01/03/2003 | WO2003000934A1 Bion1 is a novel ion channel |
| 01/03/2003 | WO2003000930A2 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000888A2 Method for separating bacterial cells and cell components |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000872A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | WO2003000871A1 Schwann cells originating in myeloid interstitial cells |
| 01/03/2003 | WO2003000870A1 Culture method for cartilage differentiation |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000868A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000852A2 Method of producing region-specific neurons from human neuronal stem cells |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000843A2 P53 binding protein-related protein in cardiomyopathy |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000838A1 Device and method for cultivation |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000714A2 Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000288A1 Methods and compositions for activating endogenous plant pathogen defense pathways |
| 01/03/2003 | WO2003000199A2 Ilt3 and ilt4-related compositions and methods |
| 01/03/2003 | WO2003000179A2 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | WO2003000114A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002077155A3 Keratinocyte growth factor-2 |
| 01/03/2003 | WO2002074902A3 Coculture of neurons with target cells in a bi-compartmented chamber |
| 01/03/2003 | WO2002072797A3 Cell culture substrate and the use thereof |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002059276A3 Culture medium |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002055676A3 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 01/03/2003 | WO2002046430A3 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002030215A3 Growing marine fish in freshwater |
| 01/03/2003 | WO2002026942A3 Human liver cell line |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020620A3 Monoclonal antibody against ovarian carcinoma |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002016557A3 Tissue engineering scaffolds promoting matrix protein production |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010768A3 Model for alzheimer's disease and other neurodegenerative diseases |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002008264A3 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002000856A3 Protein glycosylation modification in pichia pastoris |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | WO2001094549A9 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081551A8 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001073087A8 Cestrum yellow leaf curling virus promoters |
| 01/03/2003 | WO2001034902A3 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451637A1 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | CA2451486A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | CA2451437A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | CA2451380A1 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451266A1 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450950A1 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |